Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue Suppl 2
301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
Free
Online download statistics by month:
Online download statistics by month: November 2021 to August 2024
Abstract
Full
Pdf
Nov 2021
218
0
18
Dec 2021
108
0
20
Jan 2022
70
0
14
Feb 2022
82
0
21
Mar 2022
324
0
22
Apr 2022
170
0
22
May 2022
96
0
23
Jun 2022
68
0
10
Jul 2022
82
0
14
Aug 2022
116
0
7
Sep 2022
68
0
11
Oct 2022
56
0
6
Nov 2022
94
0
18
Dec 2022
60
0
3
Jan 2023
64
0
12
Feb 2023
44
0
3
Mar 2023
18
0
6
Apr 2023
102
0
18
May 2023
48
0
11
Jun 2023
48
0
2
Jul 2023
80
0
11
Aug 2023
40
0
3
Sep 2023
60
0
11
Oct 2023
42
0
3
Nov 2023
60
0
6
Dec 2023
52
0
5
Jan 2024
22
0
1
Feb 2024
54
0
10
Mar 2024
50
0
22
Apr 2024
68
0
13
May 2024
60
0
7
Jun 2024
54
0
4
Jul 2024
54
0
12
Aug 2024
96
0
16
Total
2728
0
385
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?